Showing results (61-70 of 115) with videos related to
Sort By:
Pageof 12
Iscience|February 24, 2023
PTEN phosphatase inhibits metastasis by negatively regulating the Entpd5/IGF1R pathway through ATF6Yanlin Yu, Meng Dai, Liping Huang, et al.Proceedings of the National Academy of Sciences of the United States of America|April 9, 2014
p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancerDavid G McFadden, Amanda Vernon, Philip M Santiago, et al.The Journal of Pathology|September 7, 2012
Oncogene-dependent control of miRNA biogenesis and metastatic progression in a model of undifferentiated pleomorphic sarcomaJeffrey K Mito, Hooney D Min, Yan Ma, et al.Cell Reports|August 7, 2020
Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven CancerAria Vaishnavi, Michael T Scherzer, Conan G Kinsey, et al.Nature|January 11, 2013
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistanceMeghna Das Thakur, Fernando Salangsang, Allison S Landman, et al.Science Translational Medicine|April 8, 2010
Resiliency and vulnerability in the HER2-HER3 tumorigenic driverDhara N Amin, Natalia Sergina, Deepika Ahuja, et al.Genes & Development|August 16, 2012
The intermediate-activity (L597V)BRAF mutant acts as an epistatic modifier of oncogenic RAS by enhancing signaling through the RAF/MEK/ERK pathwayCatherine Andreadi, Lai-Kay Cheung, Susan Giblett, et al.Cell Cycle (Georgetown, Tex.)|May 27, 2005
Conditional EGFR promotes cell cycle progression and prevention of apoptosis in the absence of autocrine cytokinesJohn G Shelton, Linda S Steelman, Steven L Abrams, et al.Nature Genetics|March 14, 2009
Braf(V600E) cooperates with Pten loss to induce metastatic melanomaDavid Dankort, David P Curley, Robert A Cartlidge, et al.Proceedings of the National Academy of Sciences of the United States of America|October 23, 2013
Phenformin enhances the therapeutic benefit of BRAF(V600E) inhibition in melanomaPing Yuan, Koichi Ito, Rolando Perez-Lorenzo, et al.Pageof 12